Bullfrog Ai Holdings Inc (BFRG) Stock Price, Quote & News

Company Profile

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment...

Industry: Health Information Services

Sector: Healthcare

Phone: 240 658 6710

Website: www.bullfrogai.com

Address:

325 Ellington Boulevard, Unit 317, Gaithersburg, United States

Newmoves Aug. 18 at 7:44 PM

$BFRG did they regain compliance so they don’t have to do a reverse split?

1 · Reply

rayzer202 Aug. 18 at 5:27 AM

$BFRG if you read into the quarterly report, they have already achieved milestone payment from Pharma pilot prior to June 30 (not received but earned). They didn’t announce anything for this, so I would think a big PR coming with a lot more then just milestone payment

0 · Reply

Casualtradess Aug. 17 at 10:52 PM

$BFRG potential upfront fees, milestones and royalties from partnerships.zz

0 · Reply

WeTheMarket Aug. 15 at 8:30 PM

$BFRG Link to BFRG InvestorsHub site https://investorshub.advfn.com/Bullfrog-AI-Holdings-Inc-BFRG-41901

0 · Reply

WeTheMarket Aug. 15 at 2:31 PM

$BFRG Updated insights from ChatGPT. The 10-Q is actually somewhat reassuring on the Nasdaq question. We now know BFRG proactively requested the second extension, and its equity position appears materially better than the prior Nasdaq equity deficiency. I think the odds of receiving the extension are high.

0 · Reply

JuanValdex Aug. 14 at 11:08 PM

$BFRG you can tell the stock is just about washed out when you see posts like this ,, peasants looking for breadcrumbs... when the focus should be ---------------

1 · Reply

JuanValdex Aug. 14 at 10:51 PM

$BFRG a year ago WTM argued with me bout accrued revenue in the filing . $BFRG now lists the rev accrued.

0 · Reply

rayzer202 Aug. 14 at 10:22 PM

$BFRG extension announcement would be next Monday or Tuesday

0 · Reply

WeTheMarket Aug. 14 at 9:25 PM

$BFRG On July 30, 2026, the Company sent a letter to Nasdaq requesting an extension of 180-calendar day grace period to regain compliance with the Minimum Bid Price Requirement. If the Company does not regain compliance within the allotted compliance periods, including any extensions that may be granted by Nasdaq, the Company’s listed securities will be subject to delisting. The Company would thereafter have the right to appeal a determination to delist the Company’s securities, and the Company’s securities would remain listed on the Nasdaq Capital Market until the completion of the appeal process. While the Company plans to review all available options, including, if necessary, effecting a reverse stock split, there can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the compliance period, secure a second 180-day period to regain compliance with the Minimum Bid Price Requirement, . . .

0 · Reply

WeTheMarket Aug. 14 at 9:14 PM

$BFRG Link to SEC Form 10-Q released after market close. https://ir.bullfrogai.com/sec-filings/all-sec-filings/content/0001628280-26-057121/0001628280-26-057121.pdf

0 · Reply

BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference

Jul 21, 2026, 4:15 PM EDT - 4 weeks ago

BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026

Jun 24, 2026, 1:00 PM EDT - 7 weeks ago

Water Tower Research Publishes Initiation of Coverage Report on BullFrog AI Holdings, Inc., "Helping Big Pharma Look Before It Leaps in Drug Discovery"

Jun 2, 2026, 8:00 AM EDT - 2 months ago

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

2026-05-29T20:40:11.000Z - 2 months ago

Bullfrog AI registers to sell 2M shares of common stock for holders

2026-04-22T12:20:47.000Z - 4 months ago

Bullfrog AI regains compliance with Nasdaq

Apr 22, 2026, 7:30 AM EDT - 4 months ago

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

Apr 14, 2026, 7:30 AM EDT - 4 months ago

BullFrog AI Announces Participation at AACR Annual Meeting

2026-04-13T13:44:13.000Z - 4 months ago

BullFrog AI issues shareholder letter highlighting recent progress, outlook

2026-04-13T13:29:17.000Z - 4 months ago

BullFrog AI issues shareholder letter highlighting recent progress, outlook

Apr 13, 2026, 7:30 AM EDT - 4 months ago

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

Mar 30, 2026, 4:55 PM EDT - 5 months ago

Bullfrog AI stock offers a rare opportunity for investors to take profit

2026-03-30T11:57:55.000Z - 5 months ago

Bullfrog AI enters commercial agreement with pharmaceutical company

Mar 30, 2026, 7:30 AM EDT - 5 months ago

BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder

Mar 25, 2026, 8:00 AM EDT - 5 months ago

BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

Mar 11, 2026, 8:00 AM EDT - 5 months ago

BullFrog to Host Webinar on New Precision AI Capability

2026-02-04T12:35:55.000Z - 7 months ago

Bullfrog AI to unveil new precision AI capability

Feb 4, 2026, 7:30 AM EST - 7 months ago

BullFrog AI to Unveil New Precision AI Capability

2026-01-27T12:40:13.000Z - 7 months ago

Bullfrog AI publishes whitepaper on data harmonization

2026-01-06T12:46:40.000Z - 8 months ago

Bullfrog AI highlights presentation of data from bfLEAP

Jan 6, 2026, 7:30 AM EST - 8 months ago

BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer

2025-12-30T13:36:00.000Z - 8 months ago

Bullfrog AI sees several developments as ‘important catalysts’ in 2026

2025-11-18T15:00:27.000Z - 9 months ago

Bullfrog AI publishes whitepaper on AI in Bioinformatics

2025-10-10T21:30:12.000Z - 11 months ago

Bullfrog AI files to sell 5M shares of common stock for holders

2025-09-30T12:25:15.000Z - 11 months ago

Bullfrog AI announces expansion of internal sales organization

2025-09-25T12:10:49.000Z - 11 months ago

Bullfrog AI, Sygnature announces official sales launch of BullFrog networks

2025-09-23T12:10:46.000Z - 11 months ago

Bullfrog AI to showcase AI-powered clinical data solutions in Xtalks Webinar

2025-09-08T12:15:17.000Z - 1 year ago

Bullfrog AI provides update on collaboration with Eleison

Sep 8, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI's bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration

Jul 28, 2025, 4:30 PM EDT - 1 year ago

BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference

2025-07-22T12:10:49.000Z - 1 year ago

Bullfrog AI announces white paper on smarter drug development

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development

2025-07-17T12:26:56.000Z - 1 year ago

Bullfrog AI launches bfPREP, an AI-powered data preparation module

2025-07-10T12:26:28.000Z - 1 year ago

Bullfrog AI unveils BullFrog Data Networks Solutions Library

2025-06-20T12:10:19.000Z - 1 year ago

Bullfrog AI ‘s Juan Felipe Beltran to be speaker at XTalks webinar

Jun 20, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

Jun 12, 2025, 8:00 AM EDT - 1 year ago

BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

Dec 27, 2024, 8:00 AM EST - 1 year ago

BullFrog AI Issues Letter to Stockholders

Dec 17, 2024, 4:30 PM EST - 1 year ago

BullFrog AI Announces Appointment of Chief Financial Officer

Oct 22, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium

Oct 21, 2024, 1:00 PM EDT - 1 year ago

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 21, 2024, 11:45 AM EDT - 1 year ago

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 12:01 PM EDT - 1 year ago

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 9:30 AM EDT - 1 year ago

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 15, 2024, 7:30 AM EDT - 2 years ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

Oct 9, 2024, 7:30 AM EDT - 2 years ago

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Aug 26, 2024, 8:00 AM EDT - 2 years ago

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 25, 2024, 7:30 AM EDT - 2 years ago

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

May 29, 2024, 8:00 AM EDT - 2 years ago

Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12

May 16, 2024, 8:00 AM EDT - 2 years ago

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

Apr 26, 2024, 9:00 AM EDT - 2 years ago

BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Mar 8, 2024, 8:00 AM EST - 2 years ago

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

Feb 21, 2024, 12:01 PM EST - 2 years ago

BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock

Feb 9, 2024, 8:00 AM EST - 2 years ago

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

Feb 5, 2024, 10:15 AM EST - 2 years ago

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

Feb 5, 2024, 10:00 AM EST - 2 years ago

BullFrog AI Announces Closing of $5.7 Million Public Offering

Feb 1, 2024, 9:56 AM EST - 2 years ago

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

Feb 1, 2024, 9:00 AM EST - 2 years ago

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

Jan 26, 2024, 7:30 AM EST - 2 years ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Jan 17, 2024, 12:01 PM EST - 2 years ago

This AI stock is up 30% on Wednesday: find out more

Jan 17, 2024, 7:00 AM EST - 2 years ago

BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

Jan 16, 2024, 8:00 AM EST - 2 years ago

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Jan 11, 2024, 4:05 PM EST - 2 years ago

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

Dec 29, 2023, 8:00 AM EST - 2 years ago

BullFrog AI Issues Letter to Shareholders

Dec 6, 2023, 7:00 AM EST - 2 years ago

BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity

Oct 27, 2023, 9:00 AM EDT - 3 years ago

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ASPI

Oct 18, 2023, 9:00 AM EDT - 3 years ago

BullFrog AI to Present at Benzinga All Access Event on October 20

Oct 5, 2023, 8:00 AM EDT - 3 years ago

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Sep 25, 2023, 8:00 AM EDT - 3 years ago

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

Newmoves Aug. 18 at 7:44 PM

$BFRG did they regain compliance so they don’t have to do a reverse split?

1 · Reply

rayzer202 Aug. 18 at 5:27 AM

0 · Reply

Casualtradess Aug. 17 at 10:52 PM

$BFRG potential upfront fees, milestones and royalties from partnerships.zz

0 · Reply

WeTheMarket Aug. 15 at 8:30 PM

$BFRG Link to BFRG InvestorsHub site https://investorshub.advfn.com/Bullfrog-AI-Holdings-Inc-BFRG-41901

0 · Reply

WeTheMarket Aug. 15 at 2:31 PM

0 · Reply

JuanValdex Aug. 14 at 11:08 PM

$BFRG you can tell the stock is just about washed out when you see posts like this ,, peasants looking for breadcrumbs... when the focus should be ---------------

1 · Reply

JuanValdex Aug. 14 at 10:51 PM

$BFRG a year ago WTM argued with me bout accrued revenue in the filing . $BFRG now lists the rev accrued.

0 · Reply

rayzer202 Aug. 14 at 10:22 PM

$BFRG extension announcement would be next Monday or Tuesday

0 · Reply

WeTheMarket Aug. 14 at 9:25 PM

0 · Reply

WeTheMarket Aug. 14 at 9:14 PM

$BFRG Link to SEC Form 10-Q released after market close. https://ir.bullfrogai.com/sec-filings/all-sec-filings/content/0001628280-26-057121/0001628280-26-057121.pdf

0 · Reply

mirae1472 Aug. 14 at 4:17 PM

$BFRG The CEO doubling the salary without managing the company’s stock price!! That's too much. Hurry up and release the news!

0 · Reply

WeTheMarket Aug. 14 at 12:28 PM

$BFRG Google Gemini's take: - Evaluating the regulatory mechanics and the company's filing patterns suggests a request for a second 180-day extension from Nasdaq is considerably more likely than an immediate reverse split execution right at the primary deadline. ChatGPT's take: - If BFRG is currently compliant with the other Nasdaq requirements: I'd estimate ~85–90% probability of extension. - If there is another unresolved Nasdaq deficiency: I'd drop that substantially, perhaps to ~50–65%. - If Nasdaq believes BFRG cannot realistically cure the deficiency: The odds could become considerably worse.

0 · Reply

Newmoves Aug. 13 at 11:31 AM

$BFRG did they get an extension or are they doing a reverse split?

1 · Reply

WeTheMarket Aug. 12 at 6:38 PM

$BFRG Posted 3hrs ago on Linkedin. https://www.linkedin.com/in/vinsingh/ Link referenced in post https://bullfrogai.com/technology/

0 · Reply

rayzer202 Aug. 11 at 11:17 AM

$BFRG extension should be announced in next day or two, then PR regarding pilot with Pharma in next week or two id think. Looking good, excited to see what Pharma deal looks like with expansion, big things to come for. Bullfrog and a rerating of the stock price

1 · Reply

mirae1472 Aug. 11 at 8:43 AM

$BFRG The Nasdaq $1 compliance period is until August 10, but there hasn’t been any announcement yet?

0 · Reply

Bulltrader988 Aug. 10 at 8:23 PM

$BFRG Interesting DD. 👃👀 https://x.com/i/status/2086907965693395327

0 · Reply

tradersedge2017 Aug. 8 at 2:42 AM

$BFRG This should be a $100+ stock. I'm still holding as I think this company has a big upside opportunigy, that said I would like an explanation as to why the CEO would get a 50% raise as the stock performance of this company has been terrible. I hope there is something that the board is aware of that justifies giving this type of raise.

1 · Reply

Here4cabbage Aug. 7 at 9:58 PM

$BFRG i took my massive fucking loss. fuck this stock im moving on from it

2 · Reply

Sam201 Aug. 7 at 5:55 PM

$BFRG why so much enthusiasm here? For 0 revenue in 2026?

0 · Reply

WeTheMarket Aug. 7 at 11:09 AM

$BFRG There isn't any new SEC filing. You must be referring to the following SEC Form S-1 filed on May 29, 2026. https://ir.bullfrogai.com/sec-filings/all-sec-filings/content/0001493152-26-026390/0001493152-26-026390.pdf Relevant quotes: "This prospectus relates to the resale, from time to time, of up to 2,000,000 shares of our common stock, par value $0.00001 per share, by Lincoln Park Capital Fund, LLC." "Our common stock is listed on the Nasdaq Capital Market LLC (“Nasdaq”) under the symbol “BFRG”. The last reported sale price of our common stock on Nasdaq on May 28, 2026 was $0.72 per share."

1 · Reply

BlasTheSauce69 Aug. 7 at 10:33 AM

$BFRG public offering of 2million shares for .72 cents! This is plummeting tomorrow and will see sun .50/.40 this month!

0 · Reply

Market Cap	10.30M
Revenue (ttm)	120,000.00
Net Income (ttm)	-6.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-5,416.67%
Debt to Equity Ratio	0.03

Volume	202,000
Avg Vol	168,490
Day's Range	N/A - N/A
Shares Out	18.54M
Stochastic %K	1%
Beta	-2.70
Analysts	Hold
Price Target	N/A